DRIO 0.92 (-11.54%)
US23725P2092Medical Diagnostics & ResearchDiagnostics & Research

DarioHealth (DRIO) Competitor Comparison

We are evaluating the key criteria listed to compare DarioHealth (DRIO) against its competitors in the Diagnostics & Research industry.

Linearity 5 years - DRIO ranking 4 / 58

These are the competitors of DarioHealth in the industry Diagnostics & Research ranked by linearity 5 years
1. Inotiv NOTV
190.78
2. Co-Diagnostics CODX
72.92
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. DarioHealth DRIO
31.71
5. Syneos Health SYNH
24.79
6. CareDx CDNA
19.5
7. Heska HSKA
15.42
8. Qiagen QGEN
9.39
9. Olink Holding OLK
8.53
10. Anixa Biosciences ANIX
8.33
11. Pacific Biosciences of California PACB
7.25
12. NeoGenomics NEO
7.07
13. Aspira Womens Health AWH
5.9
14. DexCom DXCM
5.35
15. Fulgent Genetics FLGT
5.09
16. PerkinElmer PKI
4.97
17. Quest Diagnostics DGX
4.6
18. Illumina ILMN
4.15
19. Neogen NEOG
4.09
20. Sotera Health SHC
3.8
21. Twist Bioscience TWST
3.78
22. Sera Prognostics SERA
3.74
23. Trinity Biotech TRIB
3.7
24. Exact Sciences EXAS
3.62
25. IQVIA Holdings IQV
3.49
26. Myriad Genetics MYGN
3.47
27. IDEXX Laboratories IDXX
3.47
28. Charles River Laboratories CRL
3.42
29. National Research NRC
3.37
30. Laboratory Corp of America Holdings LH
3.3
31. Waters WAT
3.12
32. Psychemedics PMD
3.05
33. Enzo Biochem ENZ
2.84
34. Guardant Health GH
2.82
35. Personalis PSNL
2.51
36. Bioventus BVS
2.35
37. Agilent Technologies A
2.34
38. Neuronetics STIM
2.28
39. Global Cord Blood CO
2.23
40. Exagen XGN
2.2
41. MaxCyte MXCT
2.18
42. Interpace Biosciences IDXG
2.17
43. MDxHealth MDXH
2.17
44. Precipio PRPO
2.14
45. Biodesix BDSX
1.99
46. Mettler-Toledo MTD
1.98
47. Thermo Fisher Scientific TMO
1.89
48. Prenetics Global PRE
1.88
49. Danaher DHR
1.75
50. bioAffinity Technologies BIAF
1.71
51. Icon ICLR
1.63
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.48
54. Meridian Bioscience VIVO
0.99
55. Natera NTRA
0.94
56. RadNet RDNT
0.39
57. Lantheus Holdings LNTH
0.31
58. Medpace Holdings MEDP
0.31

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.